Antimicrobial Agents Practice Questions

Q: The dose of which of the following antimicrobial agents may not require alteration in patients with deranged glomerular filtration rate (GFR)?

Cefoperazone. **Explanation:** The primary factor determining whether a drug requires dose adjustment in renal failure is its **route of elimination**. Most beta-lactam antibiotics are primarily excreted unchanged by the kidneys via glomerular filtration and tubular secretion. However, drugs that undergo significant **biliary (hepatic) excretion** do not require dose modification in patients with a deranged Glomerular Filtration Rate (GFR). **Why Cefoperazone is correct:** Cefoperazone is a third-generation cephalosporin that is predominantly excreted in the **bile** (approx. 70-80%). Because its clearance is independent of renal function, it is safe to use at standard doses in patients with renal impairment. **Analysis of Incorrect Options:** * **Cefepime (Option A):** A fourth-generation cephalosporin almost entirely excreted by the kidneys. Accumulation in renal failure can lead to neurotoxicity (e.g., encephalopathy, seizures). * **Cefuroxime (Option B):** A second-generation cephalosporin excreted primarily via the renal route; requires dose reduction as GFR declines. * **Tetracycline (Option D):** Most tetracyclines (except Doxycycline and Minocycline) are excreted in the urine and can worsen azotemia due to their anti-anabolic effect. They are generally contraindicated in renal failure. **High-Yield Clinical Pearls for NEET-PG:** * **Cephalosporins safe in renal failure:** Cefoperazone and Ceftriaxone (both have significant biliary excretion). * **Tetracycline of choice in renal failure:** **Doxycycline** (excreted via feces). * **Other antimicrobials not requiring renal adjustment:** Erythromycin, Azithromycin, Clindamycin, Linezolid, and Rifampicin. * **Anti-anabolic effect:** Tetracyclines (except Doxycycline) increase BUN levels, making them dangerous in uremic patients.

Q: Which is the best anti-tubercular drug effective against intermittently dividing mycobacteria?

Rifampicin. **Explanation:** The effectiveness of anti-tubercular drugs (ATD) is often categorized by their action on specific subpopulations of *Mycobacterium tuberculosis* based on their metabolic activity and location. **1. Why Rifampicin is correct:** Mycobacteria exist in four distinct metabolic pools. **Rifampicin** is uniquely effective against **intermittently dividing organisms** (also known as "persisters" or "spurters"). These bacteria are usually dormant but undergo short bursts of metabolic activity. Rifampicin’s rapid bactericidal action allows it to kill these organisms during their brief active phases, making it the most important drug for **sterilizing the lesion** and preventing late relapses. **2. Why other options are incorrect:** * **Isoniazid (INH):** This is the most potent bactericidal drug, but it is primarily effective against **rapidly dividing** extracellular bacilli. It has negligible activity against dormant or intermittently active bacteria. * **Pyrazinamide:** This drug is specifically effective against mycobacteria residing in **acidic intracellular environments** (within macrophages) and at sites of inflammation. It is a "slow-growing" specialist but not the primary drug for intermittent spurters. * **Ethambutol:** This is a **bacteriostatic** drug that inhibits cell wall synthesis. It is used to prevent the emergence of resistance but lacks the potent sterilizing activity of Rifampicin. **NEET-PG High-Yield Pearls:** * **Best Sterilizing Agent:** Rifampicin (followed by Pyrazinamide). * **Best Early Bactericidal Activity (EBA):** Isoniazid (reduces sputum load in the first 48 hours). * **Site of Action:** Rifampicin acts on the DNA-dependent RNA polymerase (inhibits transcription). * **Mnemonic for Populations:** * **I**NH: **I**nside/Outside (Rapidly growing) * **P**yrazinamide: **P**hagosomes (Acidic medium) * **R**ifampicin: **R**esting/Intermittent (Sterilizing)

Q: Clostridium difficile diarrhoea is most commonly associated with which class of antibiotics?

Aminopenicillins. **Explanation:** *Clostridium difficile* infection (CDI) occurs when the normal colonic flora is suppressed by broad-spectrum antibiotics, allowing the overgrowth of toxin-producing *C. difficile*. **Why Aminopenicillins are the correct answer:** While almost any antibiotic can trigger CDI, **Aminopenicillins (Ampicillin and Amoxicillin)** are statistically the most common cause due to their high frequency of clinical use and broad-spectrum activity that significantly disrupts gut microbiota. Historically, Clindamycin was considered the most notorious "high-risk" drug per dose, but in modern clinical practice, the sheer volume of Aminopenicillin prescriptions makes them the leading cause of antibiotic-associated diarrhea. **Analysis of Incorrect Options:** * **Fluoroquinolones:** These are a major risk factor and have been associated with outbreaks of the hypervirulent NAP1/BI/027 strain. While high-risk, they are statistically secondary to penicillins and cephalosporins in total incidence. * **Macrolides:** Drugs like Erythromycin or Azithromycin have a lower propensity to cause CDI compared to beta-lactams, though they can still disrupt flora. * **Carbapenems:** These are ultra-broad-spectrum agents and carry a high risk for CDI, but because they are reserved for severe, hospital-based infections, they account for fewer total cases than the more commonly used Aminopenicillins. **High-Yield Clinical Pearls for NEET-PG:** * **Most common cause (Overall):** Aminopenicillins/Cephalosporins. * **Highest risk per dose:** Clindamycin. * **Drug of Choice (DOC):** Oral Vancomycin or Fidaxomicin (Metronidazole is now reserved for non-severe cases in resource-limited settings). * **Diagnosis:** Detection of Toxin A (enterotoxin) and Toxin B (cytotoxin) in stool via PCR or ELISA.

Q: Which drug is highly vestibulotoxic?

Streptomycin. **Explanation:** Ototoxicity is a classic side effect of several drug classes, manifesting as either **vestibulotoxicity** (vertigo, ataxia, loss of balance) or **cochleotoxicity** (tinnitus, hearing loss). **1. Why Streptomycin is correct:** Among aminoglycosides, **Streptomycin** and Gentamicin are predominantly **vestibulotoxic**. They selectively damage the sensory hair cells of the vestibular apparatus. Streptomycin is so specifically toxic to the vestibular system that it was historically used therapeutically to ablate vestibular function in patients with severe Meniere’s disease. **2. Analysis of Incorrect Options:** * **Cisplatin (Option A):** This platinum-based chemotherapeutic agent is highly **cochleotoxic**, causing permanent, high-frequency hearing loss. It is not primarily vestibulotoxic. * **Dihydrostreptomycin (Option C):** Unlike its parent drug Streptomycin, this derivative is notoriously **cochleotoxic**. It was largely discontinued because it causes severe and unpredictable hearing loss. * **Quinine (Option D):** Quinine (and Salicylates) causes "Cinchonism," which includes tinnitus and temporary hearing loss. This is usually reversible and less severe than aminoglycoside-induced damage. **3. NEET-PG High-Yield Pearls:** * **Aminoglycoside Rule of Thumb:** * **Vestibulotoxic:** Streptomycin, Gentamicin. * **Cochleotoxic:** Kanamycin, Amikacin, Neomycin, Dihydrostreptomycin. * **Both:** Tobramycin. * **Mechanism:** Aminoglycosides generate reactive oxygen species (ROS) in the inner ear and have a long half-life in the perilymph (30-50 hours), leading to progressive accumulation. * **Loop Diuretics:** Ethacrynic acid and Furosemide can cause ototoxicity, which is often synergistic when combined with aminoglycosides.

Q: Which antitubercular drug does not cross the blood-brain barrier?

Streptomycin. ### Explanation The penetration of antitubercular drugs into the cerebrospinal fluid (CSF) is a critical factor in managing tuberculous meningitis. **Why Streptomycin is the Correct Answer:** Streptomycin is an **aminoglycoside**. Aminoglycosides are highly polar, polycationic compounds. Due to their high lipid insolubility, they do not cross the blood-brain barrier (BBB) significantly, even when the meninges are inflamed. Consequently, streptomycin reaches therapeutic concentrations in the CSF only in negligible amounts, making it ineffective for CNS tuberculosis. **Analysis of Incorrect Options:** * **Isoniazid (INH):** This is a small, water-soluble molecule that penetrates the CSF exceptionally well (reaching concentrations nearly equal to plasma levels), regardless of whether the meninges are inflamed. * **Pyrazinamide:** This drug has excellent CNS penetration and reaches concentrations in the CSF that are comparable to those in the serum. It is a cornerstone in the treatment of TB meningitis. * **Rifampicin:** Although it is a large lipid-soluble molecule, it achieves therapeutic concentrations in the CSF specifically when the meninges are **inflamed**, which is the clinical state in meningitis. **NEET-PG High-Yield Pearls:** * **Excellent CSF Penetration:** Isoniazid, Pyrazinamide, Prothionamide/Ethionamide, and Linezolid. * **Good CSF Penetration (with inflammation):** Rifampicin, Levofloxacin, and Moxifloxacin. * **Poor CSF Penetration:** Streptomycin, Ethambutol (only minimal penetration even with inflammation), and PAS. * **Mnemonic:** Aminoglycosides (like Streptomycin) are "Large and Charged," which prevents them from crossing lipid membranes like the BBB.

Q: Which of the following drugs is NOT useful in Urinary Tract Infections (UTI)?

Moxifloxacin. **Explanation:** The correct answer is **Moxifloxacin**. The fundamental pharmacological concept here is the **route of elimination**. For a drug to be effective in treating a Urinary Tract Infection (UTI), it must reach therapeutic concentrations in the urine. * **Moxifloxacin:** Unlike most other fluoroquinolones, Moxifloxacin is primarily metabolized by the liver and excreted via the **biliary/fecal route**. Consequently, it does not achieve significant concentrations in the urine. Therefore, it is ineffective for UTIs but is excellent for respiratory infections (often called a "Respiratory Quinolone"). * **Ofloxacin, Levofloxacin, and Ciprofloxacin:** These drugs are primarily excreted unchanged by the **kidneys** via glomerular filtration and tubular secretion. This results in high urinary drug levels, making them effective for treating both complicated and uncomplicated UTIs. **Clinical Pearls for NEET-PG:** 1. **Moxifloxacin Rule:** "Moxifloxacin stays out of the bladder." It is the only commonly used fluoroquinolone that **does not require dose adjustment in renal failure** because of its hepatic clearance. 2. **Ciprofloxacin:** Remains the most potent fluoroquinolone against *Pseudomonas aeruginosa*, making it a preferred choice for complicated UTIs. 3. **Respiratory Quinolones:** Levofloxacin, Moxifloxacin, and Gemifloxacin are termed "respiratory quinolones" due to their enhanced activity against *S. pneumoniae*. 4. **Side Effects:** Remember the "Black Box Warning" for fluoroquinolones regarding **tendon rupture** (especially the Achilles tendon) and permanent peripheral neuropathy.

Q: Which of the following adverse effects is most likely to occur with sulfonamides?

Skin reactions. **Explanation:** **Sulfonamides** are structural analogs of PABA that inhibit dihydropteroate synthase. Their adverse effect profile is a high-yield topic for NEET-PG, with **hypersensitivity reactions** being the most frequent complication. 1. **Why Skin Reactions are Correct:** Skin reactions are the most common adverse effect of sulfonamides, ranging from mild rashes, urticaria, and photosensitivity to life-threatening conditions like **Stevens-Johnson Syndrome (SJS)** and **Toxic Epidermal Necrolysis (TEN)**. These are Type IV hypersensitivity reactions caused by the accumulation of reactive metabolites (hydroxylamines) in the skin. 2. **Analysis of Incorrect Options:** * **Neurologic effects (A):** While possible, these are rare and not the "most likely" or characteristic side effect compared to dermatological issues. * **Hematuria (B):** Sulfonamides can cause **crystalluria** (precipitation of the drug in acidic urine), which may lead to hematuria. However, this is largely prevented in modern practice by maintaining adequate hydration and urinary alkalinization, making it less common than skin reactions. * **Fanconi’s Anemia (C):** This is a genetic DNA repair defect. Sulfonamides do not cause Fanconi’s anemia, though they can cause **Aplastic Anemia** (rare) or **Hemolytic Anemia** specifically in patients with **G6PD deficiency**. **High-Yield Clinical Pearls for NEET-PG:** * **Kernicterus:** Sulfonamides displace bilirubin from albumin; they are contraindicated in newborns and near-term pregnancy. * **G6PD Deficiency:** Always remember the "Sulfas" (Sulfonamides, Sulfonylureas, Dapsone) as triggers for hemolysis. * **Drug Interactions:** They displace warfarin and phenytoin from plasma proteins, increasing their toxicity. * **Triple Sulfas:** Used historically to increase solubility and decrease the risk of crystalluria.

Q: Ganciclovir is preferred over acyclovir in which of the following conditions?

Cytomegalovirus retinitis in AIDS patients. **Explanation:** **1. Why Option D is Correct:** Ganciclovir is a synthetic analog of 2'-deoxyguanosine. While it shares a similar mechanism with acyclovir (inhibition of viral DNA polymerase), it is **10 to 100 times more potent against Cytomegalovirus (CMV)**. In CMV-infected cells, ganciclovir is monophosphorylated by a viral protein kinase called **UL97**, which allows it to reach much higher intracellular concentrations than acyclovir. Therefore, it is the drug of choice for life- or sight-threatening CMV infections, such as **CMV retinitis** in immunocompromised (AIDS) patients. **2. Why Other Options are Incorrect:** * **A, B, and C:** These conditions are caused by the Herpes Simplex Virus (HSV) and Varicella-Zoster Virus (VZV). **Acyclovir** is the preferred agent for these because it is highly effective and has a superior safety profile. Ganciclovir is significantly more toxic (causing bone marrow suppression) and is generally reserved for CMV, where acyclovir is ineffective. **3. High-Yield Clinical Pearls for NEET-PG:** * **Mechanism of Resistance:** Resistance to ganciclovir occurs due to mutations in the **UL97 gene** (preventing phosphorylation) or the viral DNA polymerase. * **Dose-Limiting Toxicity:** The most common side effect is **bone marrow suppression** (neutropenia and thrombocytopenia). This is additive if used with Zidovudine (AZT). * **Valganciclovir:** This is the L-valyl ester (prodrug) of ganciclovir with high oral bioavailability, often used for maintenance therapy in CMV retinitis. * **Foscarnet:** Used as a second-line agent for ganciclovir-resistant CMV; it does not require phosphorylation by viral kinases.

Question 1

The dose of which of the following antimicrobial agents may not require alteration in patients with deranged glomerular filtration rate (GFR)?

Accepted Answer

Cefoperazone

Answer

Cefepime

Answer

Cefuroxime

Answer

Tetracycline

Question 2

What is the recommended chemoprophylaxis for pregnant females traveling to areas endemic for chloroquine-resistant Plasmodium falciparum?

Accepted Answer

Mefloquine

Answer

Primaquine

Answer

Doxycycline

Answer

Amodiaquine

Question 3

Which is the best anti-tubercular drug effective against intermittently dividing mycobacteria?

Accepted Answer

Rifampicin

Answer

Pyrazinamide

Answer

Ethambutol

Answer

Isoniazid

Question 4

All of the following are true regarding Bedaquiline use except?

Accepted Answer

Patients should be using hormonal based birth control measures throughout the treatment period.

Answer

The patient must be >= 18 years with MDR TB.

Answer

Patients with XDR-TB are eligible for its therapy.

Answer

Pregnant patients are excluded.

Question 5

Clostridium difficile diarrhoea is most commonly associated with which class of antibiotics?

Accepted Answer

Aminopenicillins

Answer

Fluoroquinolones

Answer

Macrolides

Answer

Carbapenems

Question 6

Which drug is highly vestibulotoxic?

Accepted Answer

Streptomycin

Answer

Cisplatin

Answer

Dihydrostreptomycin

Answer

Quinine

Question 7

Which antitubercular drug does not cross the blood-brain barrier?

Accepted Answer

Streptomycin

Answer

Isoniazid

Answer

Rifampicin

Answer

Pyrazinamide

Question 8

Which of the following drugs is NOT useful in Urinary Tract Infections (UTI)?

Accepted Answer

Moxifloxacin

Answer

Ofloxacin

Answer

Levofloxacin

Answer

Ciprofloxacin

Question 9

Which of the following adverse effects is most likely to occur with sulfonamides?

Accepted Answer

Skin reactions

Answer

Neurologic effects including headache, dizziness, and lethargy

Answer

Hematuria

Answer

Fanconi's anemia

Question 10

Ganciclovir is preferred over acyclovir in which of the following conditions?

Accepted Answer

Cytomegalovirus retinitis in AIDS patients

Answer

Herpes simplex keratitis

Answer

Herpes zoster

Answer

Chickenpox

Antimicrobial Agents — MCQs

Antimicrobial Agents — MCQs

On this page

Practice by Chapter

Want unlimited practice?